Tissue-type plasminogen activator (t-PA)
Sueishi, K.; Nakashima, Y.
Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 70: 217-223
1987
ISSN/ISBN: 0047-1860 PMID: 3112446 Document Number: 298938
Document emailed within 1 workday
Related Documents
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25
Harbeck, N.; Kates, R.E.; Look, M.P.; Meijer-Van Gelder, M.E.; Klijn, J.G.M.; Krüger, A.; Kiechle, M.; Jänicke, F.; Schmitt, M.; Foekens, J.A. 2002: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Research 62(16): 4617-4622
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Turazza, F.M.; Pogna, M. 1990: Tissue-type plasminogen activator Medicina 10(1): 75-78
Fischer, B. 1990: Mechanisms of activation of tissue-type plasminogen activator Arzneimittel-Forschung 40(5): 625-632
Milligan, K.S. 1987: Tissue-type plasminogen activator: a new fibrinolytic agent Heart and Lung: the Journal of Critical Care 16(1): 69-74
Gmiński, J.; Flak, A. 1989: Tissue-type plasminogen activator--biochemistry, physiology and clinical use Wiadomosci Lekarskie 42(19-21): 1055-1059
Schleef, R.R.; Sinha, M.; Loskutoff, D.J. 1985: Characterization of two monoclonal antibodies against human tissue-type plasminogen activator Thrombosis and Haemostasis 53(2): 170-175
Von Romatowski, H.J.; Henze, T.; Tebbe, U. 1988: Recanalization of basilar artery occlusion with tissue-type plasminogen activator Deutsche Medizinische Wochenschrift 113(15): 616
Schermer, E.; Streif, W.; Genser, N.; Frühwirth, M.; Trawöger, R.; Simma, B. 2000: Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series Wiener Klinische Wochenschrift 112(21): 927-933
Reilly, T.M.; Knabb, R.M.; Chiu, A.T.; Bradfute, D.L.; Timmermans, P.B. 1989: Monoclonal antibodies to tissue-type plasminogen activator which prolong its clearance in vivo Thrombosis and Haemostasis 61(2): 259-261